Fungal pulmonary infections;Grzybice płuc

Mikologia Lekarska

Volumn 12, Issue 3, 2005, Pages 193-196

  Jankowska Konsur, Alina ^a   Baran, Eugeniusz ^a   Jankowska, Renata ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b NONE   (Poland)

Author keywords

Fungal pulmonary infection; Pulmonary aspergillosis

Indexed keywords

ANTIBIOTIC THERAPY; BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; DISEASE PREDISPOSITION; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; LEUKOCYTE COUNT; LUNG ASPERGILLOSIS; LUNG MYCOSIS; LUNG TRANSPLANTATION; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PARENTERAL NUTRITION; REVIEW; RISK FACTOR; STEROID THERAPY; TREATMENT PLANNING;

AJELLOMYCES CAPSULATUS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FILOBASIDIELLA NEOFORMANS; FUNGI; PENICILLIUM; RHIZOPUS;

EID: 25444515973     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Henderson V.J., Hirvela E.R.: Emerging and reemerging microbial threats: nosocomial fungal infections. Arch. Surg., 1996, 131, 330-337.
2. Horn R., Wong B., Kiehn T.E., Armstrong D.: Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev. Infect. Dis., 1985, 7, 646-655.
3. Chen K.-Y., Ko S.-C., Hsueh P.-R., Luh K.-T., Yang P.-C.: Pulmonary fungal infection. Emphasis on Microbiological spectra, patient outcome and prognostic factors. Chest, 2001, 120, 177-84.
4. Franquet T., Gimenez A., Hidalgo A.: Imaging of opportunistic fungal infections in immunocompromised patient. E. J. Radiol., 2004, 51, 130-138.
5. Del Favero A.: Management of fungal infections in neutropenic patients: more doubts than certainties? Int. J. Antimcrob. Agents., 2000, 16, 135-137.
6. Battegay M., Flueckiger U.: Neue Medikamente zur Behandlung systemischer Mykosen. Internist, 2005, 46, 659-670.
7. Rubio C.M., d Ocariz I.R., Gil J., Benito R., Rezusta A.: Potential fungicidial effect of voriconazole against Candida spp. Int. J. Antimicrob. Agents., 2005, 25, 264-267.
8. Ostrosky-Zeichner L., Oude Lashof A.M.L., Kullberg B.J., Rex J.H.: Voriconazole salvage treatment of invasive candidiasis. Eur. J. Clin. Microbiol. Infect. Dis., 2003, 22, 651-655.
9. Kurnatowski P.: Grzybice dróg oddechowych. [w:] Zarys mikologii lekarskiej. red. E. Baran Volumed, Wrocław, 1998, 379-391.
10. Soubani A.O., Chandrasekar P.M.: The clinical spectrum of pulmonary aspergillosis. Chest, 2002, 121, 1988-1999.
11. Fraser R.S.: Pulmonary aspergillosis: pathologic and pathogenic features. Pathol. Annual., 1993, 28, 231-77.
12. Kauffman C.A.: Quandary about treatment of aspergillomas persists. Lancet, 1996, 347, 1640.
13. Bodey G.P., Vartivarian S.: Aspergillosis. Eu. J. Clin. Microbiol. Infect. Dis., 1989, 8, 413-437.
14. Gefter W.B.: The spectrum of pulmonary aspergillosis. J. Thorac. Imaging., 1992, 7, 56-74.
15. Glimp R.A., Bayer A.S.: Pulmonary aspergilloma. Arch. Intern. Med., 1983, 143, 303-308.
16. Kay P.H.: Surgical management of pulmonary aspergilloma. Thorax, 1997, 52, 753-754.
17. Hinson K.F.W., Moon A.J., Plummer N.S.: Bronchopulmonary aspergillosis: a review and report of eight new cases. Thorax, 1952, 7, 317-333.
18. Vlahakis N.E., Aksamit T.: Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin. Proc., 2001, 76, 930-938.
19. Elliott M.W., NewmanTaylor A.J.: Allergic bronchopulmonary aspergillosis. Clin. Exp. Allergy, 1997, 27, 55-59.
20. Nepomuceno I.B., Esrig S., Moss R.B.: Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconasole. Chest, 1999, 115, 364-370.
21. Binder R.E., Faling L.J., Pugatch R.D., Mahasaen C., Snider G.L.: Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore), 1982, 61, 109-124.
22. Patterson T.F., Kirkpatrick W.R., White M., Hiemenez J.W., Wingard J.R., Dupont B., Rinaldi M.G., Stevens D.A., Graybill J.R.: Invasive Aspergillosis: disease spectrum, treatment practices, and outcomes; 13 Aspergillus Study Group. Medicine (Baltimore), 2000, 79, 250-260.
23. Karam G.H., Griffin F.M. Jr.: Invasive pulmonary aspergillosis in noncompromised, nonneutropenic hosts. Rev. Infect. Dis., 1986, 8, 357-363.
24. Daly P., Kavanagh K.: Pulmonary aspergillosis. Clinical presentation, diagnosis and therapy. Br. J. Biomed. Sc., 2001, 58, 197-205.
25. Denning D.W., Lee J.Y., Hostetler J.S. i wsp.: MAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am. J. Med., 1994, 97, 135-44.
26. Denning D.W.: Invasive aspergillosis. Clin. Infect. Dis., 1998, 26, 781-803.
27. Garbino J., Rohner P., Kolarova L. i wsp.: Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy. Infection, New York, 2003, 31, 41.
28. Cameron M.L., Barlett J.A., Gallis H.A. i wsp.: Manifestations of pulmonary cryptoccosis in patients with acquired immunodeficiency syndrome. Rev. Infect. Dis., 1991, 13, 64-67.
29. Sider L., Weskott M.A.: Pulmonary manifestations of cryptococcosis in patients with AIDS: CT features. J. Thorac. Imaging, 1994, 9, 78-84.
30. McAdams H.P., Rosado de Christenson M., Strollo D.C. i wsp.: Pulmonary mucormycosis: radiologic findings in 32 cases. AJR 1997, 168, 1541-1548.